M L 4 (Levothyroxine 25 mcg (0.025 mg))
Pill imprint M L 4 has been identified as Levothyroxine sodium 25 mcg (0.025 mg).
Levothyroxine is used in the treatment of underactive thyroid; hypothyroidism, after thyroid removal; hashimoto's disease; tsh suppression; myxedema coma (and more), and belongs to the drug class thyroid drugs. Studies show no risk during pregnancy. Levothyroxine 25 mcg (0.025 mg) is not subject to the Controlled Substances Act.
See also related documents.
Images for M L 4 (Levothyroxine 25 mcg (0.025 mg))
- 25 mcg (0.025 mg)
- 9.00 mm
- Prescription only
- Drug Class:
- Thyroid drugs
- Pregnancy Category:
- A - Studies show no risk
- CSA Schedule:
- N - Not a controlled drug
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
- butylated hydroxyanisole
sodium lauryl sulfate
FD&C Yellow No. 6
|NDC Code||Manufacturer / Repackager|
|51079-0444||UDL Laboratories Inc|
Note: Inactive ingredients may vary.
Levothyroxine sodium is associated with the treatment of:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...